RE:RE:Total sales of $3,197,000 for the first quarter of 2019 Quite amazing, this company used to have close to 70% gross margins. Now that the "state of the art" facility is done, gross margins down to 42%. So much for the supposed increase in margins after the new facility is ready. Looks like the opposite has happened. What is the company going to to if the revenue fluctuates back down? They're have a good-sized loss as it is now.
lscfa wrote: Gross margin down to 42.4%.....
whatsmyname0 wrote: - Compared to $2,270,000 for the comparative period in 2018; an increase of 41% over last year. Avenanthramides sales volumes increased by 31% for Q1 2019 vs Q1 2018.
That's a good sign, hopefully it continues.